title: [Thiopurine treatment. Significance of pharmacogenetic polymorphism].
authors.affiliation: H:S Rigshospitalet, Juliane Marie Centret, paediatrisk klinik. rh02133@rh.dk
authors.forename: K
authors.initials: K
authors.lastname: Schmiegelow
authors.forename: H
authors.initials: H
authors.lastname: Hertz
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001379:Azathioprine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D015122:Mercaptopurine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011110:Polymorphism, Genetic
chemical_list: D000964:Antimetabolites, Antineoplastic; D015122:Mercaptopurine; D001379:Azathioprine
vernacular_title: Thiopurinbehandling. Betydning af farmakogenetisk polymorfi.